![Rikin Mehta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Rikin Mehta is the founder of Lactiga, Inc. He is currently working as a Director at Licentiam, Inc.
Rikin Mehta active positions
Companies | Position | Start |
---|---|---|
Licentiam, Inc.
![]() Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Director/Board Member | - |
Lactiga, Inc.
![]() Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Licentiam, Inc.
![]() Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Technology Services |
Lactiga, Inc.
![]() Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Rikin Mehta